Holen Sie sich die Stockscreener-App
42.85
1.49%
-0.65
Vorhandelsmarkt:
42.85
Finanzdaten der Crinetics Pharmaceuticals Inc-Aktie (CRNX)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-06-30 | 2025-03-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
185.60%
1.031
|
0.361 | - | 0.399 | 0.64 |
Operating Expenses
|
16.44%
130.14
|
111.77 | 87.80 | 83.18 | 74.17 |
| Benefits Costs and Expenses |
-
|
- | - | - | - |
| Costs And Expenses |
16.44%
130.14
|
111.77 | 87.80 | 83.18 | 74.17 |
| Depreciation and Amortization |
3.68%
0.959
|
0.925 | 0.77 | 0.753 | 0.474 |
| Operating Income/Loss |
15.89%
-129.11
|
-111.41 | -87.80 | -82.78 | -73.53 |
| Nonoperating Income/Loss |
7.90%
13.47
|
14.63 | 10.97 | 8.728 | 7.069 |
| Income/Loss From Continuing Operations Before Tax |
185.60%
1.031
|
0.361 | -76.83 | 0.399 | 0.64 |
| Income/Loss From Continuing Operations After Tax |
19.49%
-115.64
|
-96.77 | -76.83 | -74.06 | -66.93 |
|
Net Income/Loss
|
19.49%
-115.64
|
-96.77 | -76.83 | -74.06 | -66.93 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
0.74%
93.79
|
93.10 | 80.09 | 79.01 | 72.29 |
| Diluted Average Shares |
0.74%
93.79
|
93.10 | 80.09 | 79.01 | 72.29 |
| Basic Earnings Per Share |
18.27%
-1.23
|
-1.04 | -0.96 | -0.94 | -0.93 |
| Diluted Earnings Per Share |
18.27%
-1.23
|
-1.04 | -0.96 | -0.94 | -0.93 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.64%
0.35%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):